BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16297463)

  • 1. Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo.
    Houli N; Loh SW; Giraud AS; Baldwin GS; Shulkes A
    Regul Pept; 2006 Mar; 134(1):9-16. PubMed ID: 16297463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa.
    Aly A; Shulkes A; Baldwin GS
    Int J Cancer; 2001 Nov; 94(3):307-13. PubMed ID: 11745407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
    Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
    Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
    Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
    Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M
    Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study.
    Marotta F; Naito Y; Minelli E; Tajiri H; Bertuccelli J; Wu CC; Min CH; Hotten P; Fesce E
    Hepatogastroenterology; 2003; 50(54):1914-8. PubMed ID: 14696432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tea can protect against aberrant crypt foci formation during azoxymethane induced rat colon carcinogenesis.
    Sengupta A; Ghosh S; Das S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):185-91. PubMed ID: 12866568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive effect of raw and cooked lentils (Lens culinaris L) and soybeans (Glycine max) against azoxymethane-induced aberrant crypt foci.
    Faris MA; Takruri HR; Shomaf MS; Bustanji YK
    Nutr Res; 2009 May; 29(5):355-62. PubMed ID: 19555818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model.
    Alain T; Wong JF; Endersby R; Urbanski SJ; Lee PW; Muruve DA; Johnston RN; Forsyth PA; Beck PL
    Cancer Gene Ther; 2007 Oct; 14(10):867-72. PubMed ID: 17627293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T
    Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats.
    Paulsen JE; Steffensen IL; Olstørn HB; Alexander J
    Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.
    Cowey SL; Quast M; Belalcazar LM; Wei J; Deng X; Given R; Singh P
    Cancer; 2005 Jun; 103(12):2643-53. PubMed ID: 15864814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol reduces inflammation and aberrant crypt foci in carcinogen-initiated rats.
    Karlsson PC; Hughes R; Rafter JJ; Bruce WR
    Cancer Lett; 2005 Jun; 223(2):203-9. PubMed ID: 15896454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of azoxymethane-induced aberrant crypt foci in rat by diphenylmethyl selenocyanate through downregulation of COX-2 and modulation of glutathione-S-transferase and lipid peroxidation.
    Ghosh S; Das RK; Sengupta A; Bhattacharya S
    Biol Trace Elem Res; 2005; 105(1-3):171-85. PubMed ID: 16034162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
    Ziliotto L; Barbisan LF; Rodrigues MA
    Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer.
    Carroll RE; Matkowskyj KA; Tretiakova MS; Battey JF; Benya RV
    Cell Growth Differ; 2000 Jul; 11(7):385-93. PubMed ID: 10939592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mucilage fraction of Sinapis alba L. (mustard) reduces azoxymethane-induced colonic aberrant crypt foci formation in F344 and Zucker obese rats.
    Eskin NA; Raju J; Bird RP
    Phytomedicine; 2007 Aug; 14(7-8):479-85. PubMed ID: 17188481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine.
    Ferrand A; Lachal S; Bramante G; Kovac S; Shulkes A; Baldwin GS
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G220-7. PubMed ID: 20395538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa.
    Aparicio T; Guilmeau S; Goiot H; Tsocas A; Laigneau JP; Bado A; Sobhani I; Lehy T
    Gastroenterology; 2004 Feb; 126(2):499-510. PubMed ID: 14762787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying effect of dietary sesaminol glucosides on the formation of azoxymethane-induced premalignant lesions of rat colon.
    Sheng H; Hirose Y; Hata K; Zheng Q; Kuno T; Asano N; Yamada Y; Hara A; Osawa T; Mori H
    Cancer Lett; 2007 Feb; 246(1-2):63-8. PubMed ID: 16517058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.